Selenophosphate synthetase 2, an enzyme involved in selenocysteine biosynthesis, has been found to be selectively essential for the survival of malignant cells but not in normal cells, especially in cancers that rely on GPX4 to protect cancer cells against ferroptosis such as breast cancer [215]. Here, GPX4 is linked to breast carcinoma.